15 Best Stocks to Buy According to Billionaire Seth Klarman

Key Takeaways

• Baupost's $5.2B 13F portfolio emphasizes margin of safety.
• Klarman stresses differentiation and tolerance for lonely positions.
• Portfolio avoids leverage, diversifies across countries and assets.
• Molina Healthcare added, $108M stake, Medicaid contract win.
• Replicating top hedge fund picks yielded 498.7% returns since 2014.

Summary

Billionaire investor Seth Klarman, who runs Baupost Group’s $5.2 billion 13F portfolio, reiterated his value‑focused philosophy in a May 2025 interview with Goldman Sachs’ John Waldron. He emphasized a strict margin‑of‑safety discipline, the need for differentiation, and a portfolio structure that avoids leverage while diversifying across geographies and asset classes. The firm’s latest filing shows a new $108 million stake in Molina Healthcare, highlighted for a lucrative Medicaid contract in Florida and a $50 billion pipeline of opportunities. Insider Monkey’s methodology claims that mimicking Baupost’s top 15 holdings has helped its quarterly newsletter generate a 498.7% return since 2014, underscoring the perceived edge of Klarman’s picks.

Pulse Analysis

Seth Klarman’s interview reinforces why his "margin of safety" mantra remains a cornerstone of modern value investing. By insisting that investors maintain a cushion large enough to be wrong, Klarman differentiates his approach from momentum‑driven strategies that dominate today’s markets. This emphasis on differentiation—being willing to hold positions that appear unpopular—creates a competitive edge, especially when market sentiment swings wildly.

Baupost Group’s portfolio construction mirrors its founder’s risk‑averse philosophy. The fund deliberately avoids leverage, spreads exposure across multiple countries, and balances holdings among various asset classes, reducing the impact of any single adverse event. Such structural guardrails align with broader industry trends toward resilience, as institutional investors increasingly prioritize downside protection amid geopolitical uncertainty and rapid technological disruption.

The latest addition, a $108 million stake in Molina Healthcare, illustrates how Klarman applies his framework to the healthcare sector. Molina’s recent Medicaid contract win in Florida and a $50 billion pipeline of opportunities suggest strong cash‑flow prospects despite modest premium growth. For investors, the stock offers exposure to a regulated, low‑income market segment that can deliver steady returns. Moreover, Insider Monkey’s data shows that emulating Baupost’s top 15 picks has historically outperformed the market, providing a data‑driven rationale for incorporating Klarman’s selections into a diversified, value‑oriented portfolio.